|
|
Frequently Asked Questions (FAQ's)
about Macular Degeneration and It's Treatment with Microcurrent
Stimulation
|
DISCLAIMER
The data presented here has
not been reviewed by the FDA, nor has it been peer reviewed.
The microcurrent devices used are approved by the FDA for
the treatment of pain, but they have not been approved for
other uses. The use of a device for an off-label use by a
physician is legal. The use of microcurrent stimulation discussed
here is only one part of a comprehensive program for supporting
visual health. Dr. Miller is not a manufacturer of these devices,
and the material presented here is informational, and is not
intended as simply a solicitation to sell devices.
If you have further questions
about the work being done by Dr. Miller, please contact his
office to arrange an appointment or consultation.
|
What Are
the Treatments Available for Macular Degeneration?
The stories that people bring
to this office are all too common. A person finds that their vision
is deteriorating. Maybe they're having trouble reading, maybe they've
failed the vision test on their driver's license exam, maybe they've
noticed some odd distortions in their vision, or trouble with night
vision, or difficulty seeing in bright sunlight. They go to see
their ophthalmologist or optician, hoping that a new pair of glasses
will make everything right, and they are told that they have macular
degeneration, that their vision will just continue to get worse
and that there is no cure, no treatment and no hope. People have
reported that they were essentially told to go home and get ready
to be blind. Worse yet are the stories of those people who have
a very sudden, abrupt and profound loss of vision in one of their
eyes. They rush to the emergency room or to their doctor's office
and they are told that they have had bleeding in their retina and
that they have macular degeneration. Sometimes people with this
story report that their doctor has later told them that they had
noticed some pigment loss and some loss of central vision and had
suspected or made the diagnosis of macular degeneration, but had
never told the patient, not wanting to worry them, because as far
as the doctor was concerned, this was a hopeless disease with no
treatment available.
But there is hope for people
with macular degeneration. There are things that can be done that
at the very least can slow the progression of the disease and there
are therapies that in some people actually bring some improvement
in vision. It is true that at this time there is no cure, no magic
pill and no miracle surgery. But again, there are treatments and
things that can be done to slow the disease and even bring improvement
in vision.
What You Can Do
Now:
In this office and in several
other centers around the country, a great deal of work has been
devoted to the treatment of macular degeneration and other retinal
diseases using microcurrent stimulation, a very specific form of
low current bioelectrical stimulation that with the current state
of the technology can improve cellular metabolism and promote some
healing in the retina. The use of microcurrent stimulation is one
part of a comprehensive set of treatments. The results have been
quite remarkable, with most of the people treated showing statistically
significant improvement in one or both eyes. We have treated people
with the dry and wet forms of macular degeneration, and younger
people with Stargardt's disease, and all of these types have responded
positively to the treatments. Please see the section, Results
From the First 120 Patients Treated. Other centers where
similar work is being done are reporting similar results. This treatment
has proven to be remarkably safe, easily done, and painless.
There has been a tremendous
amount of work done studying the effects that vitamins, supplements
and certain foods have on the course of the disease of macular degeneration.
Even the ophthalmologists tacitly acknowledge the importance of
supplements, and they routinely hand out samples of vitamins containing
zinc to people who have been newly diagnosed with macular degeneration.
Some of the earliest work looking at the importance for adequate
zinc intake for people with macular degeneration is over 30 years
old, and there has been a great deal of work done, especially in
the last 10 years, looking at the importance of vitamins and supplements,
especially antioxidant vitamins. Recommendations for the supplements
you should be taking now, based on the current state of knowledge,
are made in the section on Supplements for People With Retinal
Disease. This section also includes information about foods
that should be included routinely in the diet. For people whose
only treatment is to take vitamins and supplements, the best that
can be expected, based on the results of the research, is that the
progression of the disease will be slowed. There have been no studies
that have shown a lasting improvement in vision in people who take
supplements or combinations of supplements. Still, vitamins and
supplements are very important.
The final thing a person
can do is to start now to take excellent care of your eyes if you
don't already do so. Don't go out of doors without glasses that
provide excellent protection against ultraviolet light. If you smoke,
stop. Alcohol is toxic to the brain and central nervous system,
including the eye, and alcohol is best avoided. If you feel strongly
that a glass of wine has benefits for your health in other ways,
then certainly limit your consumption to one glass of wine per day.
Exercise regularly, eat a balanced diet and get enough sleep. If
you are under a great deal of stress, learn techniques for stress
reduction. If your cholesterol is elevated and your HDL cholesterol
("good cholesterol") is low, see your doctor or herbalist to see
how this can be corrected. If you have high blood pressure, keep
it well controlled. If you have diabetes, which is notorious for
its effects on the eyes, then keep your diabetes under very excellent
control, and make sure that your doctor is following the blood level
of your Hemoglobin A1-C. All of the above may seem like common sense,
but you cannot separate the eye from the rest of the body, and your
overall health is very important, and something that you can have
an effect on today.
What is microcurrent stimulation?
It is the therapy that involves
the application of a very precise, low current, tightly controlled
electrical current to specific points on the body. The surface of
the body is not uniform in terms of its electrical properties, and
there are specific points on the body which have very low resistance
and these are chosen as the points of treatment to allow a deeper
penetration of these low current stimulations. These points of low
electrical resistance correspond with classical acupuncture points,
and some of the points that are used with microcurrent stimulation
are chosen because it has been demonstrated that there is a benefit
to stimulation of these acupuncture points. The procedure is safe,
noninvasive and painless.
What is the technology
that is involved?
The technology is quite sophisticated
and complex. When properly designed, the technology can effect electrical
properties at the level of the cell membrane resulting in an increase
in the energy production of the cell by almost 1000%. Almost all
of the centers that are using microcurrent stimulation therapy to
treat retinal disease are using devices manufactured by MicroStim
Technology, Incorporated. Theirs is a constant current device which
tightly controls the delivery of current over a wide range of resistances,
and incorporates some patented technology that allows these very
low currents to penetrate very deeply into the tissues that are
being treated without harm. The trick is to provide a very low current
stimulation but to do it in such a way that you are treating more
than just the surface of the skin. There are many devices that are
marketed as microcurrent stimulators but that in reality are woefully
inadequate for the treatment of retinal disease. Numerous people
have come through this office who report that they have had their
eyes treated with microcurrent stimulation with no positive results
who were actually treated with inadequate technology and who did
respond positively to further treatment with an appropriate stimulator.
How does microcurrent
stimulation work?
Please go to the page "Mechanisms of Action
of MCS"
Is This a New Technology?
The use of microcurrent stimulation
for the treatment of retinal diseases is hardly new. The story begins
with a woman named Grace Halloran. Her story is told in her book
Amazing Grace, which is in print, published by North Star
Publications. She was a woman with retinitis pigmentosa, a disease
that typically presents earlier in life. Like macular degeneration,
conventional medical wisdom holds that retinitis pigmentosa is a
progressive disease that is untreatable. Grace is not a person who
gives up easily, and in her search for alternative methods of treatment,
she learned about work that was being done elsewhere in medicine
with microcurrent stimulation. She found a physical therapist who
owned a then top of the line microcurrent stimulator, and she convinced
them to let her try treating her eyes with the unit. Grace had remarkable
results, not only stopping the progression of her disease, but also
bringing about amazing improvement in her vision. Grace Halloran
has made it a life's work to help people with retinal disease.
An optometrist from South
Dakota, Leland Michael, was visiting San Francisco, Grace's home
town, when he learned of the work that Grace was doing. He set himself
up to try her treatment with the patients that he saw with macular
degeneration. He spent many years treating a group of people with
macular degeneration, with great success, bringing some improvement
in vision and significant slowing of the progression of the disease
to the majority of the people he treated. Leland Michael unfortunately
died, but he passed his work on before his death to another optometrist,
John Jarding. Jarding has presented the results of the work begun
by Leland Michael at conferences, and I first learned of their results
and methods at the Fourth International Symposium on Biologically
Closed Electric Circuits in 1997. I also first met Grace Halloran
at this conference.
When I met John Jarding and
Grace Halloran, they were both using microcurrent stimulators made
by MicroStim Technology, Inc., a company that had been founded by
Joel Rossen to manufacture stimulators that incorporated improvements
in the technology that he had patented. Both of them felt that this
was the best technology on the market. Dr. Miller had been trained
with microcurrent stimulators developed in Japan for the treatment
of musculoskeletal problems, and was using microcurrent stimulation
in his work with patients. He obtained the best unit possible from
Joel Rossen's company and set out to see what results he could obtain
treating retinal disease.
The original selection of
the points that were to be treated with microcurrent stimulation
was based on work that had been done using acupuncture to treat
retinal disease. Using his knowledge of acupuncture, and relying
on advise from other experienced acupuncturists, he made some modifications
to the protocols that had been developed for Grace Halloran. He
felt that some minor changes in the points that were treated would
make the treatment more effective. Recently, he has been adopting
some of the work from Japanese acupuncturists, incorporating this
into the work with people with macular degeneration. In addition,
if people have other problems that are suitable for treatment with
microcurrent stimulation such as arthritis, neck back or shoulder
problems, then they are trained to use the home treatment unit that
they have obtained for the treatment of their eyes to treat these
other problems. The success in treating these other problems is
often as important to people as the improvements they see in their
eyes.
The results in treating people
with macular degeneration in this office are as good or better than
that reported by others. We are quite pleased with the success that
comes from the use of microcurrent stimulation. The results from
the treatment of the first 121 patients in this office are reported
elsewhere in this document. In talking with others who have adopted
these techniques in their own offices, there appears to be a certain
constancy to the success that is obtained, and this is probably
due in large part to the technology in the microcurrent stimulator
manufactured by MicroStim, Inc. This technology, properly and conscientiously
applied brings results in all of the centers where it has been adopted.
Microcurrent stimulation
therapy is not a miracle cure for macular degeneration. It is a
therapy in the form of a very specific and controlled type of electrical
stimulation relying on some very sophisticated technology. In addition
to this stimulation therapy, there is a need for certain supplements
and vitamins that are beneficial for protecting the eye and assisting
the eye in healing some of the damage that has been done. Like any
disease, there is a need for the proper diet, exercise, and a healthy
lifestyle if you want to control this disease and not have the disease
control you.
About the Home Treatment Unit
The results from treatment with microcurrent stimulation
have been very optimistic. Not all electrical stimulation is the
same, and the improvements in vision seen with our current treatment
protocol are felt to be due to refinements and improvements in the
specific devices used. These devices deliver currents much closer
to the level of currents found naturally in the body. Other devices
use levels of current which are much stronger. The waveform and
quality of the microcurrent output of this device seems particularly
effective in stimulating the retina when the stimulation is applied
to points around the eyes and points on the surface of the body
related to the eye. This particular machine is "current-driven"
rather than "voltage-driven." This means that this machine is able
to adjust for varying resistance, and provide a stable level of
current, whereas a "voltage-driven" machine, provides a current
that is driven by voltage output without adjustment for varying
resistance. Laboratory research has shown that the parameters for
successful treatment involve tightly controlled levels of current,
waveform and frequency. At the current time, all of the practitioners
treating macular degeneration with microcurrent stimulation are
using the devices manufactured by Microstim Technologies, Inc. The
portable unit allows people to do the frequent treatments that are
required at home. This sophisticated device is easy to use, durable
and reliable, and safe. It is available only on the order of a physician.
Is it safe?
No side effects or adverse outcomes related to the
procedure have been seen so far. Again, the number of people who
have been treated has been small, and further work is needed before
the real risks, if any, are known. Specifically, no increase in
the conversion to the wet form of macular degeneration has been
seen in those treated. This means, that although this treatment
is thought to work by improving circulation, it has not been seen
to increase any tendency to bleed or produce exudates. The National
Institutes of Health recently published a Consensus Statement on
Acupuncture (November, 1997) which included studies of treatments
using microcurrent stimulation at acupuncture points for the treatment
of pain and various musculoskeletal problems. The NIH Consensus
Statement reports that, "One of the advantages……is that the incidence
of adverse effects is substantially lower that of many drugs or
other accepted medical procedures used for the same conditions."
The complete document from the NIH may be found at:
NIH
Consensus Statement on Acupuncture, 1997
What can I expect?
It is possible to experience an actual improvement
in vision. Many report that their vision becomes clearer, brighter,
after treatment. Some experience increased visual ability as measured
on visual acuity tests (ability to read an eye chart). However,
this is not true for everyone, and for those that experience an
actual improvement in their vision, maintaining the improvements
has required continuous treatment. Treatments are easily done at
home with the portable treatment unit. Anyone thinking of undertaking
this therapy needs to realize that they must commit themselves to
what may be a lifelong therapy requiring some of their time several
days each week after the initial six month period of daily treatment.
When the treatments are successful and the vision improves, the
results are not permanent. Treatment needs to be continued in order
to maintain the improvements, and those who have had improvements
in their vision and then stopped treatments have regressed. Even
those people who have not experienced an improvement in vision,
most report that their vision has stabilized. Their vision is no
longer deteriorating at an accelerated rate.. Although everyone
would love to experience improvement, with a disease such as macular
degeneration, stabilization is a valuable gain. Indeed, if all that
microcurrent stimulation accomplished was to slow or stop the progression
of the disease, it would be a valuable treatment. Again, in order
to maintain stabilization, treatment needs to be ongoing. It is
thought that this treatment works by increasing blood flow and metabolism
in the area being treated. When the treatments are stopped, it is
thought that the improved blood flow and metabolism are also stopped.
This is evidenced by the regression in vision experienced when treatment
is stopped. This can be corrected again when treatment commences
again. Microcurrent stimulation is not a cure. It is not a magic
bullet, but when applied properly, using the best possible technology,
it can bring at best real improvements in vision.
What is treatment like?
After learning in either a group or individual setting
how to self-administer treatment, individuals treat themselves at
home with the microcurrent home treatment unit. It is easy to learn
and apply, and is not painful in any way. For the first six months,
treamtment is done daily, with the body points treated weakly. The
daily treatment takes fifteen to twenty minutes, and the weekly
treatment takes about twenty-five minutes. Treatment needs to be
continued in order for any improvements and stabilization of vision
to be maintained.
Is treatment painful?
No.
For which patients is this treatment
most likely to be successful?
We have been treating people
with retinal disease in this office for two years now, and we have
just analyzed the results from the first
120 patients that we have treated. The results have been quite
gratifying. One surprise that we find in analyzing the data is how
well the people with the wet form of aged-related macular degeneration
have responded. The conventional wisdom that was given to Dr. Miller
when he first started doing these procedures was that the patients
with "wet" macular degeneration (exudative macular degeneration)
did not respond as well as those with "dry" macular degeneration
(non-exudative macular degeneration). This data shows that patients
with exudative macular degeneration respond quite positively.
The data reflects improvements
as measured in visual acuity testing. Many of these patients have
also shown improvement in their visual fields and in scoring on
color testing, but follow up data in these areas was not consistently
available. Acuity testing was available for all the patients we
have seen and so that is what we present here.
The other very pleasant surprise
was how well the patients with Stargardt's Disease have responded
to microcurrent stimulation therapy.
Can the "Wet" Form of Macular Degeneration
be Treated?
Yes. Some people with the "wet" form of ARMD have
benefited from this treatment, and we are currently treating both
the wet and dry forms of macular degeneration. The damage caused
to the retina by the exudates and bleeding can be so severe that
the retina is permanently damaged, and if you have had laser procedures,
there will be areas of permanent scarring in your retina. Still,
the response to microcurrent stimulation therapy has been very good
in those people we have treated with exudative or "wet" macular
degeneration. If you have the "wet" form of macular degeneration
in both eyes, we need to see the medical records from your recent
eye exams, or arrange for an exam, to determine the extent of your
disease before we can advise you if you should begin this treatment.
Why Doesn't
My Ophthalmologist Know About Microcurrent Stimulation?
Western physicians have been
using the technology of microcurrent stimulation since the 1960's
to treat a variety of conditions. Some of the earliest work in the
60's involved the use of this type of electrical stimulation to
promote the healing of bone fractures that were not otherwise healing.
Microcurrent stimulation is used to promote healing in soft tissue
wounds and pressure sores that are slow to heal. It is used extensively
in Sports Medicine, it is used by the plastic surgeons in certain
cases because of its ability to decrease the amount of scar that
forms after surgery, it is used with good success in the treatment
of carpal tunnel syndrome and in the treatment of tempero-mandibular
joint syndrome (a disease of the jaw). Ophthalmologists do not typically
read the literature associated with their colleagues in orthopedics,
physical medicine, sports medicine, hand surgery or oral surgery,
so they are usually unaware even that the technology exists. To
date, the work that has been done to adapt this technology to the
treatment of retinal disease has not been done by ophthalmologists
in this country so there is no work published in the literature
that they do read. There are research projects in their early stages
that the ophthalmologists are putting together, but it could be
years before there are any results published. There are unpublished
results from the few physicians that are using this technology to
treat the eye that are available. In addition there has been extensive
work in Russia using microcurrent stimulation for the treatment
of retinal disease and other eye disease that has been published
in the Russian medical literature. This data can be made available
to your eye care professional.
What Is
Medical Science Doing To Address the Problem of Macular Degeneration?
Microcurrent stimulation
and the use of various supplements and antioxidant vitamins attempt
to improve the function of the cells in the retina that are responsible
for vision, and to improve the poor blood flow that are the problems
at the core of macular degeneration and other diseases of the retina.
The main tool that the ophthalmologist
has to deal with the problem of macular degeneration is the laser.
The feared complication in macular degeneration is bleeding in the
retina. About 10% to 20% of people with macular degeneration will
at some time during the course of their disease develop bleeding
or leakage of fluid in the retina. The ophthalmologist can put a
fluorescent dye into a vein, look into the eye and see where blood
and fluid are leaking out and burn this area with a coagulating
laser with sufficient power to cause a full thickness burn in the
retina. This is analogous to using a hot poker to burn a bleeding
vessel in a wound on your body. It's crude, but it works. Bleeding,
once it begins is in itself very destructive and the use of the
laser to stop a bleeding or leaking vessel is good medicine, and
probably one of the only times when the use of the coagulating laser
is still appropriate.
Ophthalmologists who have
followed people with macular degeneration have observed that there
are many abnormal small vessels that can form in the retina, probably
as a response to the loss of normal blood flow that is a consequence
of macular degeneration. They have also noticed that it is these
small abnormal vessels that form where the leaking and bleeding
occur, and there have been many attempts to find a way to destroy
these abnormal small vessels before they bleed, in the hopes of
preventing or lessening the risk of bleeding in the future. The
earliest techniques used the coagulating laser to simply try and
destroy these vessels, but this led to a great deal of scarring
in the retina, left people with large and permanent blind spots,
and in the end did not prove useful in preventing the risk of bleeding
in the future. In fact, some studies have suggested that people
who had these laser procedures in an attempt to prevent bleeding
were actually more likely to bleed in the future. The reasons for
this were never determined. Radiation, which is very destructive
to blood vessels, was also used to try and destroy these small abnormal
vessels, but to date these procedures with radiation have not proven
useful, and in some cases are actually harmful.
There has been a tremendous
interest in drugs that can actually prevent the formation of these
small abnormal vessels. These are called anti-angiogenesis drugs
and much of the research has been in the field of cancer therapies,
where there is an interest in finding a way to prevent the body
from growing the blood vessels that are needed to feed a tumor.
You may have read about studies with thalidomide or newer experimental
drugs for the treatment of macular degeneration, and they are all
in this class of drugs. To date, none of these drugs have proven
effective for the treatment of macular degeneration or other retinal
diseases, but this is a hopeful area of study.
There has been a great deal
of news recently in the popular press about a procedure called Photodynamic
laser therapy. This is a refinement of the older techniques using
the coagulating laser that caused a full thickness burn in the retina.
In Photodynamic treatments, a lower power laser is used that by
itself cannot burn the retina. A drug is put into the blood, and
when the laser hits vessels that contain this drug, the drug is
chemically changed into a substance that is very destructive and
the vessels that contain the drug are destroyed. Again, the intention
and purpose of this therapy, as stated in the research protocols,
is to try and prevent the complication of bleeding and leakage that
can occur from these abnormal vessels. There is no expectation stated
that Photodynamic therapy will improve vision, and there is certainly
nothing in the procedure that improves the underlying metabolic
abnormalities that are so much a part of the disease of macular
degeneration. Photodynamic therapy has at least proven to be relatively
safe to date, but it will take years of follow-up to see if there
is actually a decrease in the risk of bleeding in those who are
treated. There are theoretical reasons to believe that combining
Photodynamic therapy with microcurrent stimulation, which can improve
the metabolism and functioning of the cells in the retina would
provide a benefit greater than would come either of these therapies
alone. One concern that has been voiced about Photodynamic therapy
is that the increased tendency to bleed in the subgroup of people
with earlier laser therapies was never adequately explained or understood,
and obviously the people who are in the research trials for Photodynamic
laser therapy will be followed carefully over the next 5, 10 and
15 years.
Finally, there are the surgical
procedures that are being tried on people with macular degeneration.
In the past, there have been attempts to surgically remove the abnormal
small vessels that form, but the results varied from very poor to
disastrous. More recently there has been a surgical technique called
retinal translocation. The macula is in the center of the retina,
and in this surgery a portion of the retina on the periphery that
is less affected by the disease is surgically moved into the center
of the retina to try and improve the central vision. The surgery
does nothing to correct the underlying problem of macular degeneration,
or improve metabolism or functioning of the cells of the retina,
and one of the biggest problems that the surgeons have faced is
that even after the surgery, the disease continues its progression.
People may show improvement immediately after the surgery, but with
continuing degeneration, the vision again deteriorates. At this
time, people who are considering this surgery are told that they
can expect a one-third chance that their vision will improve, a
one-third chance that there will be no improvement, and a one-third
chance that their vision will be worse after the surgery. They are
also told that even if the surgery is successful, that their disease
may continue to progress and that there is no guarantee made as
to how long any improvement will last. The first attempt at this
surgery on a human being was in December, 1998, and already several
of the patients who showed initial improvement after surgery have
reported to the press that their vision has deteriorated to where
it was before the surgery. Also, they must continue to wear the
special glasses that rotate the way the world looks to match the
rotation in their retinas after surgery. This surgery is in its
infancy and it is not recommended that you rush to try it until
better results are reported and there has been follow-up for a longer
time on the initial patients.
Return to Macular Degeneration
Home Page
From the Office of Damon P. Miller II, M.D.,
N.D.
Contact us at millermd@flash.net
Phone: (650) 948-5120
Fax: (650) 948-5360
|
|